IDO1-targeting antisense oligonucleotide (Secarna Pharmaceuticals)

N/A

Report date: 2025/01/26 17:39:51
NME

Base Information

Drug NameIDO1-targeting antisense oligonucleotide (Secarna Pharmaceuticals)
Drug Alias NameIDO-1 checkpoint inhibitor (Secarna Pharmaceuticals)IDO checkpoint inhibitor (Secarna Pharmaceuticals)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSecarna Pharmaceuticals GmbH & Co KG
China Registration ClassN/A

Develop Information

Active CompaniesSecarna Pharmaceuticals GmbH & Co KG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A